Answer
Yes. Immune-related reactions may appear weeks or months after the final administration, so new symptoms should still be reported to the oncology team.
Sources for this answer
- OPDIVO 10 mg/mL concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
- OPDIVO 600 mg solution for injection — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.